title: Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin.
abstract: BACKGROUND
  Survivors of a cardiac arrest often have persistent cardiovascular derangements following cardiopulmonary resuscitation including decreased cardiac output, arrhythmias and morphological myocardial damage. These cardiovascular derangements may lead to an increased susceptibility towards the external and internal environment of the cardiovascular system as compared to the healthy situation.
  
  
  METHODS
  Here we tested the hypothesis that the cardiovascular system in healthy rats and rats resuscitated from a cardiac arrest may be differentially affected by a transient receptor potential vanilloid type 1 agonist, by continuous intravenous infusion of dihydrocapsaicin (DHC).
  
  
  RESULTS
  Compared to baseline, infusion of DHC caused an initial increase in mean arterial blood pressure in both healthy and resuscitated rats of 25% and 10%, respectively. Also, we observed an initial response of tachycardia in both healthy and resuscitated rats of 30% and 20%, respectively. Then, at high levels of DHC infusion (> 2.0 mg/kg/hr) we observed two single episodes of transient bradycardia and hypotension in 33% of the healthy rats, which was consistent with a TRPV1 agonist induced Bezold-Jarisch reflex. In contrast, in resuscitated rats we observed multiple episodes of bradycardia/hypotension in 100% of the rats and at a dose of DHC of 0.65 mg/kg/hr. Notably, this DHC effect could be completely blocked in the resuscitated rats by pre-treatment with atropine, a muscarinic acetylcholine antagonist.
  
  
  CONCLUSIONS
  Our results indicate that the susceptibility of the rats towards TRPV1 agonist induced Bezold-Jarisch reflex is increased in those resuscitated from cardiac arrest compared to the healthy situation.
authors.affiliation: Neurokey AS, Diplomvej 372, DK-2800 Lyngby, Denmark. keld.fosgerau@gmail.com
authors.forename: Keld
authors.initials: K
authors.lastname: Fosgerau
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ristagno
authors.forename: Magdalena
authors.initials: M
authors.lastname: Jayatissa
authors.forename: Mads
authors.initials: M
authors.lastname: Axelsen
authors.forename: Jacob W
authors.initials: JW
authors.lastname: Gotfredsen
authors.forename: Uno J
authors.initials: UJ
authors.lastname: Weber
authors.forename: Lars
authors.initials: L
authors.lastname: Køber
authors.forename: Christian
authors.initials: C
authors.lastname: Torp-Pedersen
authors.forename: Charlotte
authors.initials: C
authors.lastname: Videbaek
mesh_terms: D000818:Animals; D001145:Arrhythmias, Cardiac; D002211:Capsaicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D002303:Cardiac Output, Low; D004195:Disease Models, Animal; D004554:Electric Countershock; D006323:Heart Arrest / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012151:Resuscitation; D050916:TRPV Cation Channels / Q000819:agonists; D050051:Transient Receptor Potential Channels / Q000819:agonists
chemical_list: D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D050051:Transient Receptor Potential Channels; D002211:Capsaicin; C012906:dihydrocapsaicin
references.citation: Regul Toxicol Pharmacol. 2005 Oct;43(1):66-75
references.pmid: 16051405
references.citation: Nat Rev Drug Discov. 2007 May;6(5):357-72
references.pmid: 17464295
references.citation: Rev Physiol Biochem Pharmacol. 1984;99:1-110
references.pmid: 6695127
references.citation: J Appl Physiol (1985). 1988 Dec;65(6):2641-7
references.pmid: 3145935
references.citation: J Appl Physiol (1985). 2006 Oct;101(4):1091-6
references.pmid: 16794017
references.citation: Hypertension. 1996 Oct;28(4):682-6
references.pmid: 8843898
references.citation: Crit Care Med. 1993 Jul;21(7):1046-50
references.pmid: 8319463
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):193-7
references.pmid: 6145098
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R37-46
references.pmid: 17008453
references.citation: Lancet. 2001 Apr 28;357(9265):1338-9
references.pmid: 11343743
references.citation: Curr Pharm Des. 2008;14(1):32-41
references.pmid: 18220816
references.citation: Curr Pharm Des. 2008;14(1):42-54
references.pmid: 18220817
references.citation: J Auton Nerv Syst. 1988 Sep;23(3):189-97
references.pmid: 2461407
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R64-76
references.pmid: 16973931
references.citation: Pharmacol Rev. 1999 Jun;51(2):159-212
references.pmid: 10353985
references.citation: Toxicol Sci. 2006 Jan;89(1):1-3
references.pmid: 16404782
references.citation: Crit Care Med. 1996 Dec;24(12):2035-41
references.pmid: 8968273
references.citation: J Toxicol Sci. 1996 Aug;21(3):195-200
references.pmid: 8887888
references.citation: Pharmacol Rev. 1991 Jun;43(2):143-201
references.pmid: 1852779
references.citation: Ann N Y Acad Sci. 2001 Jun;940:48-58
references.pmid: 11458703
references.citation: Eur J Pharmacol. 1985 Feb 5;108(3):315-9
references.pmid: 2580718
references.citation: Circ Res. 1992 Aug;71(2):460-70
references.pmid: 1628400
references.citation: Resuscitation. 1993 Feb;25(1):9-33
references.pmid: 8446790
references.citation: Nature. 1997 Oct 23;389(6653):816-24
references.pmid: 9349813
references.citation: Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):162-8
references.pmid: 15857679
references.citation: Curr Neuropharmacol. 2008 Mar;6(1):79-96
references.pmid: 19305789
references.citation: J Appl Physiol (1985). 2009 Apr;106(4):1142-52
references.pmid: 19131477
references.citation: Peptides. 1999;20(5):623-8
references.pmid: 10465515
references.citation: Br J Pharmacol. 1995 Jan;114(2):283-8
references.pmid: 7533612
references.citation: Regul Pept. 2008 Apr 10;147(1-3):19-24
references.pmid: 18207255
references.citation: Eur J Pharmacol. 1982 Sep 24;83(3-4):289-92
references.pmid: 6184240
references.citation: J Lab Clin Med. 2005 Nov;146(5):256-61
references.pmid: 16242524
references.citation: Br J Pharmacol. 2005 Mar;144(6):781-90
references.pmid: 15685214
references.citation: J Physiol. 2004 Jul 15;558(Pt 2):647-57
references.pmid: 15121805
references.citation: Blood Vessels. 1991;28(1-3):27-34
references.pmid: 2001477
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2005 Apr;371(4):241-4
references.pmid: 15756597
references.citation: J Pharmacol Exp Ther. 1990 Jan;252(1):179-84
references.pmid: 1688942
references.citation: J Pharmacol Exp Ther. 1972 Jun;181(3):512-21
references.pmid: 5033016